SPARK Europe will be regularly featured on the podcast series BioInnovation Spotlight “Shining a Light on The Next Big Thing“, a podcast series produced for and with LifeScience ORG.
SPARKee Dr. Felix Lorenz, was the first speaker in this new series. In the first podcast episode, he explains what technology lies behind the Captain T-Cell start-up project, how it can help transform cancer therapy for patients, and why he wanted to start a company.
Listen to the podcast on the podcast app you prefer or here on our website.
-----------------------------------------------------------------------
About the Podcast Series BioInnovation Spotlight
BioInnovation Spotlight is a podcast series about people behind early-stage translational life science across Europe whose innovative research today may be the blockbusters and game-changing technologies of tomorrow. Hosted by Dr. David Kirk. The podcast series is a production from LifeScience ORG. The podcast is free, and available via the LifeScience ORG website and many different podcast apps.
About LifeScience ORG
LifeScience ORG is the very first app-based private community where life science entrepreneurs and investors from across Europe connect to share knowledge and best practice.
About SPARK Europe
SPARK Europe is the joint network of SPARK sites all over Europe including Israel: SPARK-BIH, SPARK Finland, SPARK FLI, SPARK Poland and SPARK Tel Aviv. European SPARK programs are members of SPARK Global network. The purpose of SPARK programs is to provide the education and mentorship necessary to advance research discoveries from the bench to the bedside, hence to increase the maturity of academic and clinical discoveries towards practical solutions that address unmet needs in the life science and health tech space. The program follows the same principles that have been the cornerstones of SPARK at Stanford since it was established by Professor Daria Mochly-Rosen and Kevin Grimes in 2006 for advancing new biomedical research discoveries into promising new treatments for patients.